ããŸããŸãªè¬ãã¡ã«ããºã ãå©ç¹ããªã¹ã¯ãå®å šã§å¹æçãªçŒç管çã«é¢ããèæ ®äºé ãç¶²çŸ ãããè¬åŠçé®ççæ³ã®åœéçãªæŠèŠã
è¬åŠçé®ç: è¬ç©çæ³ã®ã°ããŒãã«ã¬ã€ã
çã¿ã¯æ®éçãªäººéã®çµéšã§ããããããã幎霢ãæåãèæ¯ã®äººã ã«åœ±é¿ãäžããŸãã广çãªçŒç管çã¯ãçæŽ»ã®è³ªãåäžãããæ©èœãå埩ãããå šäœçãªå¹žçŠãä¿é²ããããã«éèŠã§ãããã®ã¬ã€ãã§ã¯ãäžçäžã§å©çšå¯èœãªè¬åŠçé®ççæ³ã®æŠèŠã説æããããŸããŸãªè¬ç©ã¯ã©ã¹ããã®äœçšæ©åºãå©ç¹ããªã¹ã¯ãå®å šã§å¹æçãªäœ¿çšã«é¢ããèæ ®äºé ã«çŠç¹ãåœãŠãŠããŸããåå¥åãããã¢ããã€ã¹ãšæ²»çã®æšå¥šã«ã€ããŠã¯ãè³æ Œã®ããå»çå°éå®¶ã«ãçžè«ãã ããã
çã¿ã®çè§£: ã°ããŒãã«ãªèŠç¹
çã¿ã¯ãæ¥æ§çŒç (çæãå€ãã¯æªæãæè¡ã«é¢é£ãã)ãæ ¢æ§çŒç (æç¶æ§ã3 ãæä»¥äžç¶ã)ã䟵害å容æ§çŒç (çµç¹æå·ã«ãã£ãŠåŒãèµ·ãããã)ãç¥çµé害æ§çŒç (ç¥çµæå·ã«ãã£ãŠåŒãèµ·ãããã) ãªã©ãããã€ãã®ã«ããŽãªã«åé¡ã§ããŸããçã¿ã®çš®é¡ãç°ãªããšãããŸããŸãªè¬ã«å¯Ÿããåå¿ãç°ãªããããæ£ç¢ºãªèšºæãšãªãŒããŒã¡ã€ãã®æ²»çèšç»ãéèŠã«ãªããŸãã
äžççã«èŠããšãçã¿ã®èªèãšç®¡çã¯ãæåç信念ãå»çãžã®ã¢ã¯ã»ã¹ã瀟äŒçµæžçèŠå ã«ãã£ãŠå€§ããç°ãªãå¯èœæ§ããããŸããããšãã°ãäžéšã®æåã§ã¯ãäŒçµ±çãªæ²»çæ³ã代æ¿çæ³ãè¬ç©çæ³ããã奜ãŸããäžæ¹ãä»ã®æåã§ã¯ãèŠå¶äžã®å¶éãè²»çšã®ããã«ã广çãªé®çå€ãžã®ã¢ã¯ã»ã¹ãå¶éãããŠããå ŽåããããŸãã
åžè²©è¬ (OTC) ã®é®çå€
OTC é®çå€ã¯åŠæ¹ç®ãªãã§å®¹æã«å ¥æã§ãã軜床ããäžçšåºŠã®çã¿ã«å¯Ÿããæåã®æ²»çæ³ãšãªãããšããããããŸãããããã®è¬ã«ã¯æ¬¡ã®ãã®ãå«ãŸããŸãã
ã¢ã»ãã¢ãããã§ã³ (ãã©ã»ã¿ã¢ãŒã«)
ã¢ã»ãã¢ãããã§ã³ã¯ãå€ãã®åœã§ãã©ã»ã¿ã¢ãŒã«ãšããŠãç¥ãããŠãããåºã䜿çšãããŠããé®çå€ããã³è§£ç±å€ (è§£ç±å€) ã§ããé çãçèçãçºç±ã®ç·©åã«å¹æçã§ããæ£ç¢ºãªäœçšæ©åºã¯å®å šã«ã¯è§£æãããŠããŸããããäžæ¢ç¥çµç³»ã«ãããããã¹ã¿ã°ã©ã³ãžã³åæãé»å®³ãããšèããããŠããŸãã
- å©ç¹: 軜床ããäžçšåºŠã®çã¿ãçºç±ã«å¹æçã§ãæç€ºã©ããã«æçšããã°äžè¬çã«è容æ§ãé«ãã
- ãªã¹ã¯: é«çšéãŸãã¯é·æäœ¿çšãç¹ã«æ¢åã®èèçŸæ£ã®ãã人ã宿çã«ã¢ã«ã³ãŒã«ãæåãã人ã¯ãèèã®æå·ãçºçããå¯èœæ§ããããŸããæšå¥šçšéãå®ãã1 æ¥ã®æå€§å¶éãè¶ ããªãããã«ããããšãéèŠã§ãã
- ã°ããŒãã«ãªèæ ®äºé : ã¢ã»ãã¢ãããã§ã³ã¯ãäžçäžã®å€ãã®å®¶åºçšå»è¬åãã£ããããã®å®çªã§ããå ¥æå¯èœæ§ãšãã©ã³ãåã¯ç°ãªãå ŽåããããŸãããæå¹æåã¯åããŸãŸã§ãã
éã¹ããã€ãæ§æççè¬ (NSAIDs)
NSAID ã¯ãçã¿ãççãçºç±ã軜æžããè¬ã®ã¯ã©ã¹ã§ããççæ§ã¡ãã£ãšãŒã¿ãŒã§ããããã¹ã¿ã°ã©ã³ãžã³ã®ç£çã«é¢äžããã·ã¯ããªãã·ã²ããŒãŒ (COX) é µçŽ ãé»å®³ããããšã«ãã£ãŠäœçšããŸãã
- NSAID ã®çš®é¡: ã€ããããã§ã³ãããããã»ã³ãã¢ã¹ããªã³ããžã¯ããã§ãã¯ãã±ããããã§ã³ãªã©ã
- å©ç¹: é¢ç¯çãæçµçãçèã®ç·åŒµãé çãªã©ãåºç¯å²ã®çã¿ã®ç¶æ ã«å¹æçã§ãããŸããççã軜æžããçã¿ã®ç·©åã«è²¢ç®ããŸãã
- ãªã¹ã¯: èè žã®å¯äœçš (äŸ: èæœ°çãåºè¡)ãå¿è¡ç®¡ãªã¹ã¯ (äŸ: å¿èçºäœããã³è³åäžã®ãªã¹ã¯ã®å¢å )ãè èã®æå·ãããã³ã¢ã¬ã«ã®ãŒåå¿ãé·æäœ¿çšã¯ãå»çå°éå®¶ã«ããç£èŠãå¿ èŠã§ãã
- ã°ããŒãã«ãªèæ ®äºé : NSAID ã¯äžçäžã§åºãå ¥æã§ããŸãããç¹å®ã®è£œå€ãšåŒ·åºŠã¯ç°ãªãå ŽåããããŸããããšãã°ããžã¯ããã§ãã¯ã¯ãå€ãã®åœã§å±æçãªé®çã®ããã«å±æã²ã«ãšããŠå ¥æã§ããŸããç¹å®ã® NSAID ã®å ¥æå¯èœæ§ã¯ãå°åã®èŠå¶ã«ãã£ãŠç°ãªãå ŽåããããŸãã
åŠæ¹é®çå€
åŠæ¹é®çå€ã¯ãéåžžãOTC é®çå€ã«ååã«å¿çããªãäžçšåºŠããé床ã®çã¿ã«äœ¿çšãããŸãããããã®è¬ã«ã¯æ¬¡ã®ãã®ãå«ãŸããŸãã
ãªããªã€ã
ãªããªã€ãã¯åŒ·åãªé®çå€ã§ãããè³ãšèé«ã®ãªããªã€ãå容äœã«çµåããŠãçã¿ã®ç¥èŠã軜æžããŸãããããã¯éåžžãæè¡ãå€å·åŸã®é床ã®çã¿ããŸãã¯ä»ã®æ²»çæ³ã§ååã«ã³ã³ãããŒã«ãããŠããªãæ ¢æ§çŒçã®ç¶æ ã®ããã«äºçŽãããŠããŸãã
- ãªããªã€ãã®çš®é¡: ã¢ã«ãããã³ãã€ã³ããªãã·ã³ãã³ããããã³ãã³ããã§ã³ã¿ãã«ããã©ãããŒã«ãªã©ã
- å©ç¹: é床ã®çã¿ã®ç·©åãç¹ã«æè¡ãæªæåŸã®æ¥æ§çŒçã«éåžžã«å¹æçã§ãã
- ãªã¹ã¯: äžæ¯ãäŸåçãåŒåžæå¶ã䟿ç§ãåãæ°ãååãç æ°ãèªç¥é害ããªããªã€ãã¯ãå»çå°éå®¶ã®ç¶¿å¯ãªç£ç£ã®äžã§æ éã«äœ¿çšããå¿ èŠããããŸããéå°æåã®ãªã¹ã¯ã¯é«ããç¹ã«ã¢ã«ã³ãŒã«ãŸãã¯ä»ã® CNS æå¶å€ãšçµã¿åããããšé«ããªããŸãã
- ã°ããŒãã«ãªèæ ®äºé : ãªããªã€ãã®å ¥æå¯èœæ§ãšåŠæ¹æ £è¡ã¯ãäžçäžã§å€§ããç°ãªããŸããäžéšã®åœã§ã¯ãäžæ¯ãä¹±çšã®æžå¿µãããªããªã€ãã®äœ¿çšã«é¢ãã峿 ŒãªèŠå¶ããããŸãããä»ã®åœã§ã¯ãããèªç±ãªåŠæ¹ã¬ã€ãã©ã€ã³ããããŸããäžçä¿å¥æ©é¢ (WHO) ã¯ãçŒç管çã®ããã®ãªããªã€ãã®é©åãªäœ¿çšã«é¢ããã¬ã€ãã³ã¹ãæäŸããé®çãšäžæ¯ããã³æå®³äœçšã®ãªã¹ã¯ã®ãã©ã³ã¹ãåãããšã®éèŠæ§ã匷調ããŠããŸããããšãã°ãç·©åã±ã¢ã®ããã®ãªããªã€ããžã®ã¢ã¯ã»ã¹ã¯ãå€ãã®äœæåŸåœããã³äžæåŸåœã§å€§ããªèª²é¡ãšãªã£ãŠããŸãã
ç¥çµé害æ§çŒçè¬
ç¥çµæå·ã«ãã£ãŠåŒãèµ·ããããç¥çµé害æ§çŒçã«ã¯ãå€ãã®å Žåãç¥çµç³»ãæšçãšããç¹å®ã®è¬ãå¿ èŠã§ãããããã®è¬ã«ã¯æ¬¡ã®ãã®ãå«ãŸããŸãã
- æãã€è¬: äžç°ç³»æãã€è¬ (äŸ: ã¢ãããªãããªã³ããã«ããªãããªã³) ããã³ã»ãããã³-ãã«ãšããããªã³ååã蟌ã¿é»å®³è¬ (SNRI) (äŸ: ãã¥ããã»ãã³ããã³ã©ãã¡ãã·ã³) ã¯ãè³ãšèé«ã®ç¥çµäŒéç©è³ªã¬ãã«ã調ç¯ããããšã«ãããç¥çµé害æ§çŒçã®è»œæžã«åœ¹ç«ã¡ãŸãã
- æããããè¬: ã¬ããã³ãã³ãšãã¬ã¬ããªã³ã¯æããããè¬ã§ãããç¥çµé害æ§çŒçã®æ²»çã«ã广çã§ãããããã¯ãç¥çµçްèã®è奮æ§ãäœäžãããããšã«ãã£ãŠäœçšããããã«ãã£ãŠçã¿ã®ä¿¡å·ãæžå°ãããŸãã
- å©ç¹: ç³å°¿ç æ§ãã¥ãŒããããŒã垯ç¶ç±ç¹åŸç¥çµçãããã³ç·ç¶çççãªã©ã®ç¥çµé害æ§çŒçç¶æ ã®ç®¡çã«å¹æçã§ãã
- ãªã¹ã¯: å¯äœçšã¯ç¹å®ã®è¬ã«ãã£ãŠç°ãªããŸãããç æ°ãããŸãã壿žã䟿ç§ãããã³äœéå¢å ãå«ãŸããå ŽåããããŸããäžéšã®æãã€è¬ã¯ãå¿è¡ç®¡ç³»ã®å¯äœçšãåŒãèµ·ããå¯èœæ§ããããŸãã
- ã°ããŒãã«ãªèæ ®äºé : ç¥çµé害æ§çŒçè¬ã®å ¥æå¯èœæ§ãšåŠæ¹æ £è¡ã¯åœã«ãã£ãŠç°ãªãå ŽåããããŸããå°éã®ãã€ã³ã¯ãªããã¯ãç¥çµç§å»ãžã®ã¢ã¯ã»ã¹ããç¥çµé害æ§çŒçã®ç®¡çã«åœ±é¿ãäžããå¯èœæ§ããããŸãã
çåŒç·©å€
çåŒç·©å€ã¯ãçèã®ãããããŸãã¯ç·åŒµã«é¢é£ããçã¿ã«åŠæ¹ãããããšããããŸãããããã®è¬ã¯ãçèããªã©ãã¯ã¹ãããçèã®ããã°ãã軜æžããããšã«ãã£ãŠäœçšããŸãã
- çåŒç·©å€ã®çš®é¡: ã·ã¯ããã³ã¶ããªã³ããã¯ããã§ã³ããã¶ããžã³ãªã©ã
- å©ç¹: çèã®ããããããã³é¢é£ããçã¿ã®ç·©åã«å¹æçã§ãã
- ãªã¹ã¯: ç æ°ãããŸãã壿žãããã³äŸ¿ç§ã¯äžè¬çãªå¯äœçšã§ããäžéšã®çåŒç·©å€ã¯ç¿æ £æ§ã«ãªãå¯èœæ§ããããŸãã
- ã°ããŒãã«ãªèæ ®äºé : çåŒç·©å€ã¯äžè¬çã«äžçäžã§å ¥æå¯èœã§ããããã®åŠæ¹æ £è¡ã¯ç°ãªãå ŽåããããŸãããããã¯ãçåŠçæ³ãéåãªã©ãä»ã®é®çæŠç¥ãšçµã¿åãããŠäœ¿çšââãããããšããããããŸãã
è£å©é®çè¬
è£å©é®çè¬ã¯ãäž»ã«é®çã®ããã«èšèšãããŠããŸããããç¹å®ã®çš®é¡ã®çã¿ã®ç®¡çã«åœ¹ç«ã€å¯èœæ§ããããç¹ã«ä»ã®é®çè¬ãšçµã¿åãããŠäœ¿çšââãããšåœ¹ç«ã¡ãŸãã
- ã³ã«ãã³ã¹ããã€ã: ãã¬ãããŸã³ããããµã¡ã¿ãŸã³ãªã©ã®è¬ã¯ãé¢ç¯çãç¥çµå§è¿«ãªã©ã®ç¶æ ã®çã¿ã®ç·©åã«åœ¹ç«ã€ççã軜æžã§ããŸãããã ããã³ã«ãã³ã¹ããã€ãã®é·æäœ¿çšã¯é倧ãªå¯äœçšãåŒãèµ·ããå¯èœæ§ããããããéåžžã¯çæçãªçŒç管çã«äœ¿çšãããŸãã
- 屿é®çè¬: ãªãã«ã€ã³ãã«ããµã€ã·ã³ãªã©ã®è¬ãå«ãã¯ãªãŒã ãã²ã«ãããã³ãããã¯ã屿çãªé®çãæäŸã§ããŸãããªãã«ã€ã³ã¯ãã®é åã麻çºãããã«ããµã€ã·ã³ã¯ç¥çµçµæ«ãçã¿ã®ä¿¡å·ã«éæã«ããŸãã
- ã°ããŒãã«ãªèæ ®äºé : è£å©é®çè¬ã®å ¥æå¯èœæ§ãšäœ¿çšã¯ãå°åã®èŠå¶ããã³å»çæ £è¡ã«ãã£ãŠç°ãªãå ŽåããããŸãã屿é®çè¬ã¯äžè¬çã«è容æ§ãé«ãã屿çãªé®çã«åœ¹ç«ã€ãªãã·ã§ã³ãšãªããŸãã
å®å šã§å¹æçãªçŒç管çã®ããã®èæ ®äºé
广çãªçŒç管çã«ã¯ãå人ã®ç¹å®ã®çŒçç¶æ ãç æŽãããã³å¥œã¿ââãèæ ®ããå æ¬çãªã¢ãããŒããå¿ èŠã§ããéèŠãªèæ ®äºé ãæ¬¡ã«ç€ºããŸãã
- æ£ç¢ºãªèšºæ: çã¿ã®æ ¹æ¬åå ãç¹å®ããæ²»çã®æ±ºå®ãå°ãã«ã¯ã培åºçãªå»åŠçè©äŸ¡ãäžå¯æ¬ ã§ãã
- åå¥åãããæ²»çèšç»: çŒç管çã¯ãå人ã®ç¹å®ã®ããŒãºãšå¥œã¿ã«åãããŠèª¿æŽããå¿ èŠããããŸããããã«ã¯ãè¬ç©çæ³ãçåŠçæ³ãå¿ççãµããŒããããã³ãã®ä»ã®æ²»çæ³ã®çµã¿åãããå«ãŸããå ŽåããããŸãã
- è¬ã®å®å šæ§: åŠæ¹ããããšããã«é®çå€ã䜿çšããæœåšçãªå¯äœçšãè¬ç©çžäºäœçšã«æ³šæããããšãéèŠã§ããå»çå°éå®¶ã«ãã宿çãªã¢ãã¿ãªã³ã°ã¯ãç¹ã«åŠæ¹é®çå€ãé·æé䜿çšããå Žåã¯äžå¯æ¬ ã§ãã
- éè¬çåŠçãªã¢ãããŒã: éåãçåŠçæ³ããããµãŒãžãéŒæ²»çãèªç¥è¡åçæ³ãªã©ã®éè¬çåŠçãªã¢ãããŒãã¯ãçŒç管çã«ãããŠéèŠãªåœ¹å²ãæããããšãã§ããŸãã
- é®çãžã®ã°ããŒãã«ã¢ã¯ã»ã¹: é®çè¬ããã³ãµãŒãã¹ãžã®å ¬å¹³ãªã¢ã¯ã»ã¹ã確ä¿ããããšã¯ãã°ããŒãã«ãªå¥åº·äžã®åªå äºé ã§ããããã«ã¯ãã³ã¹ããèŠå¶äžã®å¶éãèªèã®æ¬ åŠãªã©ãã¢ã¯ã»ã¹ã«å¯Ÿããéå£ã«å¯ŸåŠããããšãå«ãŸããŸããWHO ã¯ãçŒç管çãäžçäžã®ãã©ã€ããªãã«ã¹ã±ã¢ã·ã¹ãã ã«çµ±åããããšãæå±ããŠããŸãã
å»çå°éå®¶ã®åœ¹å²
å»çå°éå®¶ã¯ãçŒç管çã«ãããŠéèŠãªåœ¹å²ãæãããŸãã圌ãã¯ã§ãã:
- çã¿ã®è©äŸ¡ãšèšºæ: çã¿ã®æ ¹æ¬åå ãç¹å®ããããã«ã培åºçãªè©äŸ¡ã宿œããŸãã
- æ²»çèšç»ã®äœæ: 忣è ã®ç¹å®ã®ããŒãºã«å¯Ÿå¿ããåå¥åãããæ²»çèšç»ãäœæããŸãã
- è¬ã®åŠæ¹: é©åãªé®çå€ãåŠæ¹ãããã®æå¹æ§ãšå¯äœçšãç£èŠããŸãã
- æè²ã®æäŸ: çŒçç®¡çæŠç¥ãè¬ã®å®å šæ§ãããã³éè¬çåŠçãªã¢ãããŒãã«ã€ããŠæ£è ãæè²ããŸãã
- å°éå»ãžã®ç޹ä»: å¿ èŠã«å¿ããŠãçŒçå°éå»ãç¥çµç§å»ããŸãã¯çåŠçæ³å£«ãªã©ã®å°éå»ã«æ£è ã玹ä»ããŸãã
çŒç管çã®æªæ¥
çŒç管çã®åéã¯åžžã«é²åããŠãããæ°èŠã§ãã广çãªæ²»çæ³ã®éçºãç®çãšããç ç©¶ãç¶ç¶çã«è¡ãããŠããŸããããã€ãã®ææãªç ç©¶åéã«ã¯ã次ã®ãã®ããããŸãã
- æ°ããè¬: æ°èŠãªäœçšæ©åºãšå¯äœçšã®å°ãªãæ°ããè¬ã®éçºã
- æšççæ³: çã¿ã®æ ¹æ¬åå ã«ç¹ã«å¯ŸåŠããæšççæ³ã®éçºã
- åå¥åå»ç: éºäŒçæ å ±ããã®ä»ã®åã ã®ç¹æ§ã䜿çšããŠãçŒçç®¡çæ²»çã調æŽããŸãã
- é«åºŠãªãã¯ãããžãŒ: æ ¢æ§çŒçã®æ²»çã®ããã®ç¥çµèª¿ç¯ãåçå»çãªã©ã®é«åºŠãªãã¯ãããžãŒã®éçºã
çµè«
è¬åŠçé®çã¯ãOTC è¬ããåŠæ¹è¬ãŸã§ãçã¿ã管çããããã®ããŸããŸãªéžæè¢ãæäŸããŸããããŸããŸãªçš®é¡ã®çã¿ãè¬ã®äœçšæ©åºãå©ç¹ãããã³ãªã¹ã¯ãçè§£ããããšã¯ãçŒç管çã«é¢ããæ å ±ã«åºã¥ããæ±ºå®ãäžãããã«äžå¯æ¬ ã§ãã广çãªçŒç管çã«ã¯ãå人ã®ç¹å®ã®ããŒãºãšå¥œã¿ââãèæ ®ããå»çå°éå®¶ãšæ£è éã®é£æºãå«ã¿ãé®çãžã®ã¢ã¯ã»ã¹ã®ã°ããŒãã«ãªæ Œå·®ã«å¯ŸåŠããå æ¬çãªã¢ãããŒããå¿ èŠã§ããååããããšã§ãäžçäžã®çã¿ã«èŠãã人ã ã®çæŽ»ãæ¹åããããšãã§ããŸãã
å 責äºé : ãã®æ å ±ã¯æè²ç®çã®ã¿ã§ãããå»åŠçãªã¢ããã€ã¹ãšèŠãªãããã¹ãã§ã¯ãããŸãããåå¥åãããã¢ããã€ã¹ãšæ²»çã®æšå¥šã«ã€ããŠã¯ãè³æ Œã®ããå»çå°éå®¶ã«å¿ ããçžè«ãã ããã